The data presented here are consistent with previous reports that show that in breast cancer, in contrast to non-Hodgkins lymphoma, higher tumour protein expression of BCL2 is associated with improved survival (Callagy et al. 2006) (Callagy et al. 2008) (Dawson et al. 2010). The gene discussed is BCL2; the disease is neoplasm.